Combating AMR with Antimicrobial Peptides
A unique RNAi therapeutic to induce endogenous Antimicrobial Peptide Secretion against AMR infection
This technology releases a cocktail of natural antimicrobial peptides that are safe for the tissue and recalcitrant to the evolution of resistance.
- Infection prevention
- Alternative antimicrobials
- Antimicrobial stewardship
- Microbial diagnostics
- Antimicrobial compound/strategy
- Removal antibiotics/bacteria
- Market entry
- Marketed product
- Joint Venture
Infectious disease area:
We are initiating a new private venture, budding out of inStem (Academic Institute), looking for co-developers, and investors interested in the pre-clinical and phase-1 trials of our innovation.
A new venture budding out of inStem – developing RNAi therapies to combat AMR infections and accelerate wound-healing.
We are a team with translational research and commercialization experience in the domain of wound-healing, skin fibrosis, and allied diseases.